Skip to content
Research Article Open access CC BY 4.0

Update Research in Psoriasis

Xiaoning Yan, Jiawei Wu, Fuyong Jiao

International Journal of TROPICAL DISEASE & Health · pp. 37–41 · Published 3 Nov 2022

10.9734/ijtdh/2022/v43i211361

Abstract

Psoriasis is now more recognized as a chronic-lymphocyte mediated inflammatory and proliferous skin disease. In European countries, the prevalence of psoriasis is 1%~3%, so the study of psoriasis is very important. With the study of immune pathogenesis and the progress of genetic engineering technology, it has been gradually developed a wide range of biological agents, And achieved good results in clinical trials or clinical treatment. This paper discusses the typical clinical manifestations, genetic research and treatment of psoriasis.

Psoriasis clinical treatment chronic inflammatory disease skin disease

Cited by 2

Article metrics

Real usage data collected on this platform.

10

Page views

0

PDF downloads

2

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.